Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Net Margin (2016 - 2025)

iBio (IBIO) has disclosed Net Margin for 16 consecutive years, with 5670.0% as the latest value for Q3 2025.

  • Quarterly Net Margin changed N/A to 5670.0% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 8229.0% through Dec 2025, down 464980.0% year-over-year, with the annual reading at 4594.25% for FY2025, 38803.0% down from the prior year.
  • Net Margin for Q3 2025 was 5670.0% at iBio, down from 2581.5% in the prior quarter.
  • The five-year high for Net Margin was 10.39% in Q2 2021, with the low at 6254.76% in Q3 2021.
  • Average Net Margin over 5 years is 2478.86%, with a median of 2182.0% recorded in 2024.
  • Peak annual rise in Net Margin hit 392874bps in 2021, while the deepest fall reached -440135bps in 2021.
  • Over 5 years, Net Margin stood at 6254.76% in 2021, then skyrocketed by 89bps to 688.33% in 2022, then crashed by -95bps to 1344.0% in 2023, then plummeted by -62bps to 2182.0% in 2024, then tumbled by -160bps to 5670.0% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 5670.0%, 2581.5%, and 2182.0% for Q3 2025, Q2 2025, and Q4 2024 respectively.